Yahoo Web Search

Search results

    • Analyst Report: Catalent Inc.

      Argus Research via Yahoo Finance· 51 minutes ago

      It reports results for two segments: Biologics and Pharma and Consumer Health. The Biologics segment provides biologic cell-line; develops and manufactures cell< ...

    • Is Bluebird Bio Stock a Buy?

      Is Bluebird Bio Stock a Buy?

      The Motley Fool via AOL· 6 hours ago

      Bluebird Bio worth the risk? The challenge of gene editing Bluebird Bio has three approved gene-editing therapies: Zynteglo, Skysona, and Lyfgenia. The...